E-Folder - Business

My day-trading journey began after I purchased a stock trading course. I f

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ollowed the course outline and traded stocks in hopes of cashing in on the

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

roaring 90’s. When the stock market corrected in 2000, I couldn't pay the

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

continuous marginals and consequently lost all my money, approx $200K!

Abo

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ut 5 years later, I was ready to jump back in the game. This time trading

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

oreign currencies, the biggest trading market in the world. I purchased the

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

4XMade Easy software (with the green and red arrows) for a heft three gran

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

d. In addition I paid a monthly live feed and demo traded for over 2 years

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

but could never predict with any degree of accuracy the direction of the m

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

arket. As a result, I ended up on the wrong side of the trade at a loss.

H

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

wever, I did learn that if I could only stay in a trade long enough by goin

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

g with the long-term trends, I would make money. But the big problem with

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

following the long-term trend is: you have to have a lot of money in your

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

account to stay in the market during the often occurring reversals.

When I

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

found out about The Freedomrocks system I finally found what I was looking

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

for. During my 15-day free trial period I was really surprised at the simp

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

le elegance of the system. I found that it did for me everything that I co

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

uld never do before. Amazingly, the system allows me to trade without a lo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

t of money to invest, no expensive software to buy, no live-feeds, no chart

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

s to predict, no staying up all night when the foreign markets are volatile

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/16274/e-folder-My-Forex-Discovery.html">My Forex Discovery</a>

BB link (for phorums):
[url=http://www.e-folder.org.ua/article/16274/e-folder-My-Forex-Discovery.html]My Forex Discovery[/url]

Some industries are keeping current with innovative packaging technologies better than others. Packaging innovation can move your business from a commodity driven product into a premium product category. Not only that, it can build sales and create its own unique niche with little or no competition. Entire new categories of product have been created around a single niche market that may not have existed a few years ago.

These days it seems hard to speak to a customer service person. One has to go through a mill to often, and the may not get the answers needed. Good customer communications, timely done, are a must to gain or keep customers.

A manufacturer complains that his customers rarely return the satisfaction surveys he sends out. A leading resort gets back just 30% of the comment cards left for guests inside their fancy rooms. One government agency had a response rate of only 6% when they sent out an 11-page survey. What’s going on here? Why is the...

Tags

Links

E-Folder - My Forex Discovery

Related Articles: